BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8167623)

  • 1. [Rheumatoid arthritis and multiple myeloma. Apropos of 22 cases. Results of a multicenter national survey].
    Flipo RM; Deprez X; Fardellone P; Duquesnoy B; Delcambre B
    Rev Rhum Ed Fr; 1993 Apr; 60(4):269-73. PubMed ID: 8167623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
    Lila AM; Mazurov VI; Novik AA
    Ter Arkh; 1997; 69(2):50-2. PubMed ID: 9173578
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-sectional epidemiological survey of rheumatoid arthritis patients seen in private practice in France. Descriptive results (1629 cases).
    Sany J; Dropsy R; Daurès JP
    Rev Rhum Engl Ed; 1998; 65(7-9):462-70. PubMed ID: 9785392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid arthropathy in the course of multiple myeloma.
    Fautrel B; Fermand JP; Sibilia J; Nochy D; Rousselin B; Ravaud P
    J Rheumatol; 2002 Jul; 29(7):1473-81. PubMed ID: 12136908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple myeloma complicating rheumatoid arthritis].
    Buskila D; Sukenik S
    Harefuah; 1988 Dec; 115(11):319-21. PubMed ID: 3234972
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
    Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
    Ann Rheum Dis; 2005 Oct; 64(10):1414-20. PubMed ID: 15843454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased risk of lymphoma, leukemia and myeloma in rheumatoid arthritis].
    Izomiaki GA; Khakulinen T; Ioutsenlakhti U
    Ter Arkh; 1979; 51(12):86-9. PubMed ID: 538724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rheumatoid arthritis and neoplasms].
    Duquesnoy B; Flipo RM
    Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):194S-197S. PubMed ID: 7858571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy in rheumatoid arthritis--a report of two cases.
    Murthy GL; Sahay RK; Narsimulu G; Srinivasan VR; Shantaram V
    J Assoc Physicians India; 1999 May; 47(5):544-5. PubMed ID: 10778569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
    Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
    Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of multiple myeloma with special reference to diet as risk factor.
    Vlajinac HD; Pekmezović TD; Adanja BJ; Marinković JM; Kanazir MS; Suvajdzić ND; Colović MD
    Neoplasma; 2003; 50(1):79-83. PubMed ID: 12687283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
    Wolfe F; Michaud K
    Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease.
    Srkalovic G; Cameron MG; Rybicki L; Deitcher SR; Kattke-Marchant K; Hussein MA
    Cancer; 2004 Aug; 101(3):558-66. PubMed ID: 15274069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of rheumatoid arthritis associated with multiple myeloma].
    Inoue F; Ohno T; Furukawa H
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Feb; 19(1):94-9. PubMed ID: 8681032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades.
    Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Melton LJ
    Cancer; 2004 Dec; 101(11):2667-74. PubMed ID: 15481060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic.
    Zimran A; Liphshitz I; Barchana M; Abrahamov A; Elstein D
    Blood Cells Mol Dis; 2005; 34(3):197-200. PubMed ID: 15885601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rheumatoid arthritis and risk of cancer].
    Mellemkjaer L; Linet MS; Gridley G; Frisch M; Møller H; Olsen JH
    Ugeskr Laeger; 1998 May; 160(21):3069-73. PubMed ID: 9621780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.
    Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Nunzi M; Grasso M; Falco P; Cangialosi C; Boccadoro M
    Cancer; 2005 Oct; 104(7):1428-33. PubMed ID: 16116606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
    Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.